Multi-component breastfeeding support after cesarean to boost confidence and bonding

The Effect of a Multi-Component Breastfeeding Support Program on Breastfeeding Self-Efficacy and Mother-Infant Bonding in Mothers Following Cesarean Section

Not applicable Interventional Cumhuriyet University · NCT07474402

This program will be tested to see if it helps mothers who had cesarean births feel more confident about breastfeeding and bond better with their babies.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment100 (estimated)
Ages18 Years and up
SexFemale
SponsorCumhuriyet University Academic / other
Locations1 site (Sivas, Merkez)
Trial IDNCT07474402 on ClinicalTrials.gov

What this trial studies

Cesarean delivery can delay early breastfeeding, limit skin-to-skin contact, and reduce early mother–infant interaction because of postoperative pain and delayed mobilization. This pretest–posttest controlled trial delivers a multi-component breastfeeding support program to primiparous mothers after cesarean delivery and compares outcomes with a control group. Breastfeeding self-efficacy and mother–infant bonding are measured before and after the intervention during the early postpartum period. The intervention is provided at the Obstetrics Service and Lactation Counseling Clinic of Sivas Cumhuriyet University Hospital between February and August 2026.

Who should consider this trial

Good fit: Primiparous mothers aged 18 or older who delivered by cesarean section, are exclusively breastfeeding healthy and stable infants, can read Turkish, have a mobile phone, and can attend follow-up visits are ideal candidates.

Not a fit: Mothers with postpartum complications, medical or psychiatric conditions preventing breastfeeding, infants with severe health issues or requiring NICU care, multiple pregnancies, or who already received prenatal breastfeeding education may not receive benefit.

Why it matters

Potential benefit: If successful, the program could help mothers feel more confident breastfeeding and strengthen early mother–infant bonding after cesarean delivery.

How similar studies have performed: Previous breastfeeding support interventions have often improved maternal breastfeeding self-efficacy and breastfeeding outcomes, so this program builds on existing supportive evidence.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Primiparous mothers who have completed pregnancy

Mothers who delivered by cesarean section (C/S)

Mothers in the early postpartum period

Mothers aged 18 years and older

Mothers who are exclusively breastfeeding

Mothers with healthy and stable infants

Mothers with no medical conditions that may interfere with breastfeeding

Mothers who can read and understand Turkish and complete the data forms

Exclusion Criteria:

* Mothers who experienced postpartum complications

Infants with severe health problems, congenital anomalies, or requiring intensive care

Infants hospitalized in neonatal intensive care unit

Mothers with medical or psychiatric conditions that prevent breastfeeding

Mothers with multiple pregnancies (twins, triplets, etc.)

Mothers who cannot attend follow-up visits during the study

Mothers without mobile phones

Mothers who received breastfeeding education during pregnancy

Where this trial is running

Sivas, Merkez

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Breastfeeding Self-EfficacyMother-Infant AttachmentBreastfeeding Consultancy TrainingPrimigravida WomenCesarean SectionMaternal-Infant BondingBreastfeeding SupportPostpartum Period
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.